FDA clears Novo Nordisk's weight loss drug Saxenda – Santa Cruz Sentinel

FDA clears Novo Nordisk's weight loss drug SaxendaSanta Cruz SentinelThe FDA has approved three weight loss pills in recent years. It cleared Vivus Inc.'s Qsymia and Arena Pharmaceuticals Inc.'s Belviq in 2012 and granted approval to Orexigen Therapeutics Inc.'s drug Contrave in September. While analysts initially …and more »